ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

Obit: Shirley Lansky, 66, Illinois Cancer Center Director, Dead.

November 30, 2001

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

Institute of Medicine Elects 80 New Members

October 24, 2014

ODAC Vote On CPT-11 Changes Standard Of Care For Advanced Colorectal Cancer.

March 24, 2000

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998